Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-08-21 2019-08-21
Drug Identification Number
Brand name SODIUM IODIDE I-131 CAPSULES SODIUM IODIDE I-131 CAPSULES
Common or Proper name SODIUM IODIDE I-131 CAPSULES SODIUM IODIDE I-131 CAPSULES
Company Name MALLINCKRODT RP CANADA INC MALLINCKRODT RP CANADA INC
Ingredients SODIUM IODIDE I-131 SODIUM IODIDE I-131
Strength(s) 0.75mCi, 2mCi, 3mCi, 4mCi, 5mCi, 6mCi, 7mCi, 8mCi, 10mCi, 12mCi, 15mCi, 17mCi, 20mCi, 50mmCi, 100mCi 0.75mCi, 2mCi, 3mCi, 4mCi, 5mCi, 6mCi, 7mCi, 8mCi, 10mCi, 12mCi, 15mCi, 17mCi, 20mCi, 50mmCi, 100mCi
Dosage form(s) Capsule Capsule
Route of administration Oral Oral
Packaging size All All
ATC code V09FX V09FX
ATC description Thyroid Thyroid
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-20 2019-08-20
Remaining supply date 2019-08-20 2019-08-20
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments